HIV/AIDS following sexual assault in Jamaican children and adolescents. A case for HIV post-exposure prophylaxis

West Indian Medical Journal

Volumn 53, Issue 5, 2004, Pages 352-355

  Steel Duncan, J C ^a   Pierre, R ^a   Evans Gilbert, T ^a   Rodriguez, B ^a   Christie, Celia D C ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; NELFINAVIR; STAVUDINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; CHILD ABUSE; CLINICAL ARTICLE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DEMOGRAPHY; DRUG DOSE REGIMEN; FEMALE; FEVER; FLU LIKE SYNDROME; GENITAL HERPES; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAMAICA; LABORATORY TEST; MALE; MYALGIA; SEXUAL CRIME; SEXUALLY TRANSMITTED DISEASE; SORE THROAT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ANTI-HIV AGENTS; CHEMOPREVENTION; CHILD; CHILD ABUSE, SEXUAL; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; JAMAICA; LAMIVUDINE; MALE; RAPE; RISK FACTORS; ZIDOVUDINE;

EID: 10644220288     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Jamaica Constabulary Force. Age group for Victims 2003. Statistics Department, Commissioner's Office. Jamaica Constabulary Force, 2004.
2. Hope Enterprises. A knowledge, attitudes and practices study for AIDS in Jamaican schools. In: A Portfolio of AIDS/STD Behavioural Interventions and Research. Washington DC: Pan Am Health Organization, 1992.
3. Anderson G. Youngsters engage in sex at early age. The Sunday Gleaner, Jamaica, April 4, 2004. http://www.jamaica-gleaner.com
4. National Family Board 1993. Contraceptive Prevalence Survey, Jamaica; National Family Board, 1994.
5. Jamaica Constabulary Force. Centre for the Investigation of Sexual Offences and Child Abuse (CISOCA) information pamphlet. Jamaica Constabulary Force, December 2001.
6. Christie CDC. "A Paediatric and Perinatal HIV/AIDS Leadership Initiative in Kingston, Jamaica"; Funded by the Elizabeth Glaser Pediatric AIDS Foundation, International Leadership Award 1-ILA-11-01. The University of the West Indies Medical Alumni Association, 7th International Conference, Nov 6-8, 2003, Nassau, platform presentation. West Indian Med J 2003; 52: (Suppl 5); abstract 5-7.
7. Weinberg GA. Post-exposure prophylaxis against human immunodeficiency virus infection after sexual assault. Pediatr Infect Dis J 2002; 21: 959-60.
8. Jenny C, Hooton TM, Bowers A, Copass MK, Krieger JN, Hillier SL et al. Sexually transmitted diseases in victims of rape. N Engl J Med 1990; 322: 713-6.
9. Bramberger JD, Waldo C, Gerberding JL, Katz MH. Postexposure prophylaxis for human immunodeficiency virus (HIV) infection following sexual assault. Am J Med 1999; 106: 323-6.
10. Lurie P, Miller S, Hecht F, Chesney M, Lo B. Postexposure prophylaxis after nonoccupational HIV exposure. JAMA 1998; 280: 1769-73.
11. Gostin LO, Lazzarini Z, Alexander D, Brandt AM, Mayer KH, Silverman DC. HIV testing, counseling, and prophylaxis after sexual assault. JAMA 1994; 271: 1436-44.
12. Centers for Disease Control and Prevention. Updated US Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. Morb Mortal Wkly Rep 2001; 50: 1-52.
13. New York State Department of Health, AIDS Institute and Rape Crisis Program. Guidelines for HIV postexposure prophylaxis following sexual assault. http://www.nynjaetc.org/curriculum/Sexual%20A.ppt
14. Gerberding J. Prophylaxis for occupational exposure to HIV. Ann Intem Med 1996; 125: 497-501.
15. Connor EM, Sperling RS, Geber R, Kiselev P, Scott G, O'Sullivan MJ et al for the Pediatric AIDS Clinical Trial Groups Protocol 076 Study Group. Reduction of maternal-infant transmission of Human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331: 1173-80.
16. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C et al. Intrapartum and neonatal single dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomized trial. Lancet 1999; 354: 795-802.
17. AIDS Institute. Post exposure prophylaxis guidelines.
18. Merchant RC, Keshavarz R. Human immunodeficiency virus postexposure prophylaxis for adolescents and children. Pediatrics 2001; 108(2). URL: http://www.pediatrics.org/cgi/content/full/108/2/e38
19. Centers for Disease Control and Prevention. Serious adverse effects attributed to nevirapine regimens for post exposure prophylaxis after HIV exposure - worldwide, 1997-2000. MMWR Morb Mortal Wkly Rep 2001; 49: 1153-6.